IL37 and oral cavity squamous cell carcinoma: For instance, in Oral Squamous Cell carcinoma (OSCC), IL-37 inhibited the proinflammatory effects of IL-18 and the increased IL-18/IL-37 ratio in serum predicted shorter overall and disease-free survival (179).